SGMC Health is now offering Aquablation® therapy with the new HYDROS™ Robotic System, the latest advancement in treating men suffering from benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.

Aquablation therapy, delivered with the support of an advanced, AI-powered robotic system, is clinically proven to provide significant and long-lasting relief from BPH symptoms while preserving sexual function and urinary continence. This minimally invasive procedure is designed to treat prostates of all shapes and sizes, offering men a personalized solution without compromise.

BPH is a common condition that affects millions of men as they age, often resulting in symptoms such as difficulty urinating, incomplete bladder emptying, urgency, increased frequency, and nighttime urination. If left untreated, BPH can lead to serious health complications, including permanent bladder or kidney damage, bladder stones, and incontinence. Studies show that 1 in 2 men between the ages of 51 and 60 experience BPH, and 99 percent of men report that the condition negatively impacts their quality of life.

“The burden of BPH can significantly reduce a man's quality of life,” said John Losee, MD, Urologist at SGMC Health. “With Aquablation therapy, we can offer effective, lasting relief from urinary symptoms while preserving both sexual function and continence, outcomes that have been difficult to achieve with many traditional treatments."

What sets Aquablation therapy apart is its combination of real-time ultrasound imaging and digital cystoscopy, which offers surgeons a comprehensive, multi-dimensional view of the prostate. This enables the creation of a tailored treatment plan that precisely targets only the tissue that needs to be removed while sparing critical structures. The robotic system then uses a heat-free waterjet to execute the surgeon-defined plan, resulting in a highly accurate and reproducible procedure.

The new HYDROS Robotic System represents the next evolution in Aquablation therapy. Drawing on data from more than 50,000 procedures, HYDROS includes FirstAssist AI™ treatment planning, advanced imaging capabilities, robotic precision, and an improved surgical workflow. These enhancements are designed to increase efficiency in the operating room, elevate the experience for both surgeons and staff, and deliver consistent, high-quality outcomes for patients.

Aquablation therapy is supported by five-year clinical data demonstrating significant and durable symptom relief while preserving sexual function and continence. With the addition of this cutting-edge technology, SGMC Health continues to expand its offerings and provide advanced, patient-centered care to the South Georgia and North Florida region.

Patients seeking more information about Aquablation therapy are encouraged to contact SGMC Urology at 229-241-1188. The clinic is located at 3294 N Oak Street Extension in Valdosta. Appointments are available for those interested in exploring this advanced treatment option.

To learn more, visit sgmc.org.